56 results
Page 3 of 3
6-K
EX-99.1
c2qoymm
16 May 23
YS Biopharma’s PIKA Rabies Vaccine Receives Phase 3 Clinical Trial Approval in Pakistan
10:38am
F-1/A
q851n b162
12 May 23
Registration statement (foreign) (amended)
4:05pm
6-K
EX-99.1
9obl8xxk1zn4rh6hn
18 Apr 23
YS Biopharma Announces Record Vaccine Revenues and Preliminary
8:00am
F-1
vxwir5
12 Apr 23
Registration statement (foreign)
8:49am
F-4
EX-99.2
dts60lz2 n5pjg17k4
28 Dec 22
Registration of securities (foreign)
6:58am
F-4
EX-10.6
o4v4ipll92csy1
28 Dec 22
Registration of securities (foreign)
6:58am
F-4
pj0pqjsj 53
28 Dec 22
Registration of securities (foreign)
6:58am
F-4
EX-10.9
l7mx73
28 Dec 22
Registration of securities (foreign)
6:58am
DRS/A
zxnwaiev5nc
7 Dec 22
Draft registration statement (amended)
12:00am
DRS/A
EX-10.9
tno5lu8gka xunm
14 Nov 22
Draft registration statement (amended)
12:00am
DRS/A
kc5qzed hndidna7s3
14 Nov 22
Draft registration statement (amended)
12:00am
DRS
cl7tbky9
3 Oct 22
Draft registration statement
12:00am
425
bhhwqz17v0o 6wsdny
30 Sep 22
Business combination disclosure
9:25am
425
EX-99.2
1l69fzperxqteugjz9jp
30 Sep 22
Business combination disclosure
9:25am
425
EX-99.1
l4rvltcz2f hxvyby21
30 Sep 22
Business combination disclosure
9:25am
425
EX-2.1
tmn ohu3mvshxgbi
30 Sep 22
Business combination disclosure
9:25am